| |
| |
|
| Insider
Information: |
Smith Cynthia |
| Relationship: |
Director |
| City: |
Coppell |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
132,535 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$267,030 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
132,535 |
|
|
| Total
Value |
$267,030 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zs Pharma, Inc. |
ZSPH |
Chief Commercial Officer |
2015-12-17 |
0 |
2015-12-08 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2023-06-06 |
95,233 |
2019-06-06 |
0 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2021-06-03 |
0 |
Premium* |
|
|
Spero Therapeutics Inc |
SPRO |
|
2023-10-05 |
35,000 |
2022-09-15 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2023-08-11 |
2,302 |
2023-08-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SPRO |
Spero Therapeutics Inc |
|
• • – |
2023-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
35,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2023-08-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,302 |
2,302 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2023-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
95,233 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
Director |
– • – |
2022-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2021-12-28 |
4 |
D |
$38.25 |
$127,487 |
D/D |
(3,333) |
0 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2021-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,333 |
3,333 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
51,533 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2020-06-08 |
4 |
AS |
$12.10 |
$55,261 |
D/D |
(4,567) |
37,833 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
42,400 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-11-20 |
4 |
B |
$3.52 |
$52,800 |
D/D |
15,000 |
28,700 |
0.01 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
13,700 |
0 |
- |
|
| ZSPH |
Zs Pharma, Inc. |
Chief Commercial Officer |
• – – |
2015-12-17 |
4 |
D |
$90.00 |
$1,133,820 |
D/D |
(12,598) |
0 |
0 |
- |
|
| ZSPH |
Zs Pharma, Inc. |
Chief Commercial Officer |
• – – |
2015-12-08 |
4 |
OE |
$10.92 |
$100,011 |
D/D |
9,155 |
9,155 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
